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BACKGROUND: Although several studies have investigated the association of the Mediterranean diet with overall mortality or risk of
specific cancers, data on overall cancer risk are sparse.
METHODS: We examined the association between adherence to Mediterranean dietary pattern and overall cancer risk using data from
the European Prospective Investigation Into Cancer and nutrition, a multi-centre prospective cohort study including 142 605 men and
335 873. Adherence to Mediterranean diet was examined using a score (range: 0–9) considering the combined intake of fruits and
nuts, vegetables, legumes, cereals, lipids, fish, dairy products, meat products, and alcohol. Association with cancer incidence was
assessed through Cox regression modelling, controlling for potential confounders.
RESULTS: In all, 9669 incident cancers in men and 21 062 in women were identified. A lower overall cancer risk was found among
individuals with greater adherence to Mediterranean diet (hazard ratio¼ 0.96, 95% CI 0.95–0.98) for a two-point increment of the
Mediterranean diet score. The apparent inverse association was stronger for smoking-related cancers than for cancers not known to
be related to tobacco (P (heterogeneity)¼ 0.008). In all, 4.7% of cancers among men and 2.4% in women would be avoided in this
population if study subjects had a greater adherence to Mediterranean dietary pattern.
CONCLUSION: Greater adherence to a Mediterranean dietary pattern could reduce overall cancer risk.
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Since the early 1990s, growing evidence indicates that the
Mediterranean diet, a concept first proposed by Keys in the mid-
1980s (Keys et al, 1986), has a beneficial influence on health and
longevity (Trichopoulou et al, 1995, 2005; Trichopoulou, 2004; Sofi
et al, 2008, 2010). The Mediterranean diet reflects the dietary
pattern prevalent in the olive growing areas of the Mediterranean
region up to the 1960s (Trichopoulou, 2004). It is characterised
by high intake of (i) vegetables, (ii) legumes, (iii) fruits and nuts,
(iv) minimally processed cereals, (v) moderately high intake of
fish, (vi) high intake of monounsaturated lipids coupled with low
intake of saturated fat, (vii) low-to-moderate intake of dairies,
(viii) low intake of meat products, and (ix) regular but mode-
rate intake of alcohol (Trichopoulou et al, 1995). Adherence to a
Mediterranean dietary pattern has been measured using a score
with components reflecting intake of each dietary factor (Tricho-
poulou et al, 1995, 2005; Trichopoulou, 2004).
Investigating the association between adherence to Mediterra-
nean diet and overall cancer risk would provide an integrated
estimate of the potential beneficial effects of this habit on cancer
burden. Although most studies have investigated the relationship
between adherence to Mediterranean diet and overall mortality
(Mitrou et al, 2007; Sofi et al, 2008, 2010) only a fairly small study
from the Greek European Prospective Investigation into Cancer
and Nutrition (EPIC) cohort (Benetou et al, 2008) has examined
overall cancer incidence. Results of cohort studies on the
association of adherence to Mediterranean diet with the risk of
specific cancers have also been reported (Fung et al, 2006; Reedy
et al, 2008; Cottet et al, 2009; Buckland et al, 2010; Trichopoulou
et al, 2010).
In this report, we investigate the association between adherence
to the Mediterranean dietary pattern and overall cancer risk within
the EPIC study, a prospective cohort study including participants
from 10 European countries.
MATERIALS AND METHODS
Study population and design
The EPIC study is a multi-centre prospective cohort study
designed to investigate the relationship between nutrition and
cancer. This study, described previously (Riboli et al, 2002),
recruitedB520 000 people mostly aged 25–70 years, between 1992
and 2000, in 23 centres located in Denmark, France, Germany,
Greece, Italy, The Netherlands, Norway, Spain, Sweden, and the
United Kingdom. Participants were mostly recruited from the
general population. Exceptions were the French cohort (including
female members of the health insurance for school and university
employees), the Utrecht cohort in the Netherlands (recruiting
women attending breast cancer screening), the Ragusa cohort in
Italy (based on blood donors and their spouses), the Spanish
cohorts (general population, blood donors, and civil servants) and
the Oxford cohort in the United Kingdom, including mostly
vegetarian and health-conscious volunteers. The cohorts of France,
Norway, Utrecht, and Naples were restricted to women. Among
individuals with complete exposure information, prevalent cases of
cancer (23 633), subjects with incomplete follow-up information
(9665), or with a ratio of energy intake vs energy expenditure in the
top or bottom 1% (9672) were excluded. This left 142 605 men and
335 873 women followed for a median time of 8.7 years.
Exposure assessment
At enrolment, questionnaires on lifestyle and other exposures were
administered, and anthropometric measurements were obtained.
Information on foods and beverages consumed during the year
preceding enrolment was collected using instruments developed
and validated within each centre (Margetts and Pietinen, 1997).
Self- or interviewer-administered food frequency questionnaires,
as well as 7- or 14-day record diaries (UK, and one Swedish centre)
and diet history questionnaires (Spain) were used.
The Mediterranean diet score
Adherence to a Mediterranean dietary pattern was assessed using
the 9-Unit dietary score proposed by Trichopoulou et al (1995),
including fruits and nuts, vegetables, legumes, cereals, lipids, fish,
dairy products, meat products, and alcohol. We used a variant of
this score (Trichopoulou et al, 2005), in which lipid intake was
assessed by calculating the ratio of unsaturated (the sum of
monounsaturated and polyunsaturated lipids) to saturated lipids,
to allow for the low consumption of olive oil-derived mono-
unsaturated lipids in non-Mediterranean countries (Trichopoulou,
2004). A value of 0 or 1 was assigned to each component of the
score as follows: for components that are more consumed in
Mediterranean countries (vegetables, legumes, fruits and nuts,
cereals, fish, and a high ratio of unsaturated to saturated lipids),
persons whose consumption was below or equal to the country
sex-specific median were assigned a value of 0, and 1 otherwise.
For components traditionally less consumed in Mediterranean
countries (dairy, meat, and meat products), persons whose
consumption was below the country- and sex-specific median
were assigned a value of 1, and 0 otherwise. A value of 1 was given
to persons consuming a moderate amount of alcohol (i.e., 10 to
o50 g per day of ethanol for men and 5 to o25 g per day for
women). For consumption of other quantities of alcohol a value of
0 was assigned. No information on legume consumption was
available for the Norwegian cohort but sensitivity analyses,
excluding Norway, did not influence the overall results. High
scores correspond to high adherence to the Mediterranean dietary
pattern (score’s range: 0– 9).
The score was also calculated using an alternative, more
quantitative, method described in the appendix. Obtained results
were very similar (data not shown).
Outcomes
In most countries (Denmark, Italy, The Netherlands, Norway,
Spain, Sweden, and the UK), incident cancers were identified
through a linkage with population-based cancer registries. Cancer
cases were also ascertained by active follow-up, through a health
insurance company (France), or direct contacts with study
subjects, their doctors, or their next of kin (France, Germany,
and Greece). The end of follow-up ranged from December 2002 to
December 2005, depending on centre. Cancers were classified
using the International Classification of Diseases, 10th Revision
(http://www.who.int/classifications/apps/icd/icd10online/), and the
International Classification of Diseases for Oncology (second
revision; Constance and Van Holten, 1990). Non-melanoma skin
cancers and second primary cancers were excluded.
Statistical analysis
The hazard ratio (HR) for overall cancer by the Mediterranean diet
score was estimated using Cox regression analyses, with age as
offset variable, through a categorical approach (a score equal to
0–3, 4, 5, and 6–9, dividing the population in four approximately
equal groups), and a continuous one (a two-point increment in
the score). Analyses were stratified by centre and sex, and adjusted
for height (continuous), body mass index (BMI) (continuous),
physical activity (categorical: inactive, moderately inactive, mod-
erately active, active, missing), education (categorical: none,
primary school, technical/professional school, secondary school,
higher education, not specified), total energy intake (continuous),
and tobacco smoking, categorical, comprising current amount of
smoking (1–14, 15 –24, or X25 per day cigarettes), duration of
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smoking for current smokers in 10-years categories (p10, 11 –20,
21–30, 31 –40, 41– 50, or 450 years), time since quitting (p10,
410–20, 420 years), smoking of pipe or cigar, occasional
smoking, and missing smoking information. For women, the
analyses were also adjusted for age at menarche (continuous),
pregnancy (categorical: never, ever), oral contraceptives and
hormone replacement therapy use (categorical: never, ever), and
menopausal status (categorical: premenopausal, postmenopausal,
perimenopausal, surgical postmenopausal). To explore possible
effect modification by tobacco smoking and alcohol drinking,
analyses were further stratified by these two habits, using the
following categories: never, former, and current smokers; drinkers
of o5 g per day of ethanol, 5 to o25, and X25 g per day for
women; ando10, 10 too50, andX50 g per day for men. We also
examined the association between adherence to the Mediterranean
dietary pattern and cancers known to be associated with tobacco
smoking (i.e., lung, kidney, upper aero-digestive tract, stomach,
pancreas, bladder, liver, and colorectal; IARC, 2004; Secretan et al,
2009), and to alcohol drinking (i.e., upper aero-digestive tract,
breast, liver, and colorectal cancers; Secretan et al, 2009).
Attributable fractions were estimated based on the number of
cancers that would be prevented if the whole population shifted its
diet to that observed in the highest category of the score (X6;
Hanley, 2001).
RESULTS
Overall, 9669 cases of cancer were identified in men and 21 062 in
women. A higher adherence to the Mediterranean diet was
observed in participants with higher education level, more
physically active and among never and former smokers (Table 1).
However, these results are not mutually adjusted and serve
descriptive purposes only.
Adherence to the Mediterranean dietary pattern was signifi-
cantly associated with a reduction in cancer risk (Table 2).
The HR of all cancers associated with a two-point increment of
the Mediterranean score was 0.96 (95% CI: 0.95–0.98) overall,
0.97 (95% CI 0.95– 1.00) in men, and 0.96 (95% CI 0.95–0.98)
in women. No differences were found between Southern
and Northern European countries, with HRs of 0.97 (95% CI
0.95– 0.99), and 0.96 (95% CI 0.94–0.98), respectively, for both
genders combined. The results reached the conventional level of
statistical significance only in Greece and Denmark.
A dose–response relation was observed; with lower risks
observed with increasing adherence to Mediterranean pattern
(Table 3). Overall the category-specific HRs were 0.96 (95% CI
0.93– 0.99), 0.92 (95% CI 0.89–0.95), and 0.93 (95% CI 0.90–0.96)
for scores of 4, 5, and 6–9 compared with 0–3 (P for linear
trend¼ 0.00001).
When considering overall cancer risk and the nine food groups
considered in the Mediterranean diet score, an apparent protective
effect of fruits and nuts, vegetables, cereals, and of a high ratio of
unsaturated to saturated lipids was observed (Table 4). Increased
meat consumption was associated with increased risk of cancer. In
comparison with moderate drinkers (10 to o50 g per day for men
and 5 too25 g per day for women), the HR for all cancers was 1.03
(95% CI 1.00–1.06) for non- or light drinkers (o10 g per day of
ethanol for men and o5g per day for women) and 1.12 (95% CI
1.07– 1.16) for heavy drinkers (X50 g per day for men and X25 g
per day for women).
When stratifying by tobacco smoking, the apparent protection
conveyed by adherence to the Mediterranean dietary pattern was
somewhat stronger among current smokers than among never
smokers. The HRs for a two-point increment in the score were 0.98
(95% CI 0.96–1.00) among never smokers, 0.96 (95% CI 0.93–
0.98) among former smokers, and 0.94 (95% CI 0.91–0.97) among
current smokers (P (heterogeneity)¼ 0.07; Table 5). The apparent
protective effect of adhering to the Mediterranean dietary pattern
was more pronounced among cancers known to be related to
smoking. Per two-point increment in the Mediterranean diet score,
the HR for tobacco-related cancers was 0.92 (95% CI 0.89– 0.94);
that for cancers not known to be related to tobacco 0.98 (95% CI
0.96– 1.01; P (heterogeneity)¼ 0.008). There was no difference in
the apparent effect of adherence to the Mediterranean dietary
pattern on overall cancer risk when different strata of alcohol
consumption, or alcohol-related and not related cancers were
considered (results not shown).
When translating the categorical relative risk measures into
attributable fractions, we found that 4.7% of cancers in men and
2.4% of cancers in women would be avoided if all study subjects
shifted in the highest category of the Mediterranean diet score (X6
points).
DISCUSSION
In this study, adherence to the Mediterranean dietary pattern was
associated with lower cancer risk. The association was moderately
strong, but about 4.7% of cancers in men and 2.4% of cancers in
women would have been prevented in this population if it shifted
to the category with the highest adherence to a Mediterranean
dietary pattern (score X6), adhered to by less than 50% of this
population (Table 1). It should be noticed that an attributable
fraction of 3–5% is comparable with that of other established
causes of cancer, notably obesity, and alcohol drinking (Bergstrom
et al, 2001; Boffetta et al, 2006).
Several studies have reported a beneficial effect of the
Mediterranean diet on health and longevity (Trichopoulou et al,
1995, 2005; Trichopoulou, 2004; Sofi et al, 2008, 2010). In 2008, a
meta-analysis of six cohort studies of adherence to Mediterranean
diet and cancer reported an overall relative risk of 0.94 (95% CI:
0.92– 0.96) for a two-point increase in the score (Sofi et al, 2008,
2010). Our study has some advantages over this meta-analysis.
First, it includes more than three times as many cases of cancer.
Second, it is based on a series of incident cases, whereas the meta-
analysis (Sofi et al, 2008, 2010) included four studies of cancer
mortality, two studies investigating specific cancer sites incidence
(breast and gastric cancers), and one of total cancer incidence.
Third, it is based on a standard definition of adherence to
Mediterranean dietary pattern for all contributing centres. Lastly,
it relied on a very detailed adjustment for potential confounders,
notably tobacco smoking. Results from case–control studies on
adherence to Mediterranean diet in relation to specific cancer sites
have been reported for lung cancer (Fortes et al, 2003), cutaneous
melanoma (Fortes et al, 2008), colorectal adenoma (Dixon et al,
2007), and upper aero-digestive tract cancers (Bosetti et al, 2003).
In general, they suggested a more pronounced protective effect of
this diet in comparison with our study. This could be because of
the information bias in retrospective investigations or to real
differences because of the geographic idiosyncrasies in the
association between Mediterranean diet and cancer risk. Com-
pared with our study, the NIH-AARP Diet and Health cohort study
of total cancer mortality observed a slightly stronger protective
effect for adherence to Mediterranean diet (Mitrou et al, 2007).
Our study had a substantially larger number of cancer cases, and
relied on cancer incidence rather than mortality as outcome.
However, although in most countries (Denmark, Italy, The
Netherlands, Norway, Spain, Sweden, and the UK), cancer cases
were identified through linkage with population-based cancer
registries, outcome misclassification cannot be ruled out in
countries using other methods to identify cancer cases.
The association between adherence to the Mediterranean dietary
pattern and cancer risk appeared to be stronger for smokers, and
cancers known to be related to tobacco smoking. A lower risk of
lung cancer with greater adherence to Mediterranean diet has
Mediterranean dietary pattern and cancer risk
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previously been reported (Fortes et al, 2003). Although we used
detailed adjustment for current amount of smoking, duration of
smoking for current smokers, time since quitting for former
smokers, smoking of pipe or cigar, and occasional smoking, we
cannot exclude residual confounding effect. Other adjustments for
smoking were used and yielded similar results (results not shown).
When considering cancers not known to be related to smoking, the
protective effect of adhering to Mediterranean dietary was not
statistically significant. It is possible that residual confounding by
smoking explains some the association between conformity to
Mediterranean pattern and overall and smoking related cancers.
However, exclusion of terms for tobacco smoking from the model
yielded a HR of 0.95 (95% CI 0.94– 0.97) per two-point increment
in the Mediterranean diet score compared with 0.96 (95% CI
0.95– 0.98) after detailed adjustment for smoking. This suggests
that the apparent modest protective effect of the Mediterranean
diet on overall cancer risk is real, and unlikely to be because of the
residual confounding by smoking. Similarly, in the large NIH-
AARP Diet and Health study, detailed adjustment for smoking had
only a modest effect on the association between adherence to
Mediterranean diet and cancer mortality (Mitrou et al, 2007).
Given the difference in baseline cancer risk between smokers and
non-smokers, the difference in the effect of adherence to
Mediterranean diet on an absolute scale is likely to be larger than
indicated by a relative scale. The predominant effect on smoking-
related cancers would be consistent with the anti-oxidant proper-
ties of the Mediterranean diet (Owen et al, 2000), as cigarette
smoke contains free radicals and induces oxidative damage (IARC,
2004). Of note, in a study conducted within the Greek EPIC cohort,
in which a particularly strong inverse association between
adherence to the Mediterranean diet and cancer risk was evident
(Greek sub-cohort results in Table 2), the association was stronger
for smoking unrelated cancers (Benetou et al, 2008). Residual
confounding by other variables is possible. However, the statistical
model used controlled for a large number of potential confounders
such as education, BMI, total energy intake, physical activity
further to smoking. As dietary questionnaires were used to
measure conformity to Mediterranean pattern, measurement error
is possible. However, questionnaires used were validated within
each centre (Margetts and Pietinen, 1997). Furthermore, it is likely
that any existing measurement error is randomly distributed
between cancer cases and non-cases due to, in particular, the
prospective nature of the EPIC study. Such random measurement
error would bias our results towards the null. One limitation of this
Table 1 Baseline characteristics according to categories of the Mediterranean score in the EPIC study by sex
Men Women
Score: 0–3 Score: 4 Score: 5 Score: 6–9 Score: 0–3 Score: 4 Score: 5 Score: 6–9
N (%) 43 161 (30.3) 30 770 (21.6) 29 766 (20.9) 38 908 (27.3) 110 891 (33.0) 75 166 (22.4) 69 906 (20.8) 79 910 (23.8)
Age at recruitment (years; mean±s.d.) 52.1 (10.4) 52.1 (10.1) 52.3 (10.0) 52.2 (9.9) 51.2 (9.6) 50.9 (9.7) 50.7 (9.8) 50.2 (10.1)
Height (cm; mean±s.d.) 174.5 (7.4) 174.6 (7.3) 174.8 (7.3) 175.0 (7.3) 162.1 (6.7) 162.3 (6.7) 162.3 (6.7) 162.5 (6.7)
Body mass index (mean±s.d.) 26.5 (3.7) 26.5 (3.6) 26.5 (3.6) 26.4 (3.6) 25.1 (4.5) 25.0 (4.5) 24.9 (4.4) 24.7 (4.3)
Total energy intake (kcal; mean±s.d.) 2308.2 (669.2) 2398.7 (671.2) 2466.5 (681.2) 2529.3 (654.4) 1830.8 (510.7) 1919.3 (542.7) 1987.7 (550.5) 2076.0 (537.8)
Education (N, %)
None or primary 15 966 (33.2) 10 667 (22.2) 9882 (20.6) 11 500 (23.9) 35 884 (32.4) 21 914 (29.1) 18 730 (26.8) 18 685 (23.4)
Technical/professional 10 823 (31.5) 7507 (21.8) 7173 (20.9) 8884 (25.8) 25 099 (22.6) 16 249 (21.6) 14 910 (21.3) 15 910 (19.9)
Secondary or university 14 993 (26.6) 11 804 (20.9) 12 002 (21.3) 17 543 (31.1) 45 291 (40.8) 34 125 (45.4) 33 711 (48.2) 42 235 (52.8)
Missing 1379 (35.7) 792 (20.5) 709 (18.4) 981 (25.4) 4617 (4.2) 2878 (3.8) 2555 (3.6) 3080 (3.8)
Physical activity (N, %)
Inactive 7706 (29.4) 5825 (22.2) 5532 (21.1) 7165 (27.3) 14 399 (31.4) 10.338 (22.5) 9715 (21.2) 11 445 (24.9)
Moderately inactive 10 967 (29.3) 8076 (21.6) 7990 (21.3) 10 427 (27.8) 33 932 (31.9) 23 341 (21.9) 22 351 (21.0) 26 800 (25.2)
Moderately active 13 058 (28.1) 9777 (21.0) 10 014 (21.6) 13 589 (29.3) 34 825 (31.5) 24 227 (21.9) 23 369 (21.2) 27 987 (25.3)
Active 4735 (27.2) 3611 (20.7) 3789 (21.8) 5264 (30.2) 6437 (29.4) 4689 (21.4) 4689 (21.4) 6096 (27.8)
Missing 6695 (44.4) 3481 (23.1) 2441 (16.2) 2463 (16.3) 21 298 (41.6) 12 571 (24.5) 9782 (19.1) 7582 (14.8)
Smoking status (N, %)
Never 13 999 (29.8) 10 023 (21.3) 9751 (20.8) 13 165 (28.0) 60 345 (32.3) 41 849 (22.4) 39 108 (20.9) 45 498 (24.4)
Former 13 920 (26.9) 10 922 (21.1) 11 240 (21.7) 15 668 (30.3) 22 719 (30.0) 16 587 (21.9) 16 458 (21.7) 20 017 (26.4)
Current 14 476 (34.5) 9402 (22.4) 8426 (20.1) 9632 (23.0) 25 071 (38.2) 14 873 (22.7) 12 764 (19.5) 12 749 (19.5)
Missing 766 (38.7) 423 (21.3) 349 (17.7) 443 (22.4) 2756 (35.2) 1857 (23.7) 1576 (20.1) 1646 (21.0)
Geographical region (N, %)
Southern countries 11 741 (29.5) 8661 (21.8) 8489 (21.3) 10 879 (27.3) 44 648 (32.2) 30 809 (22.3) 29 167 (21.1) 33 798 (24.4)
Greece 3172 (29.9) 2268 (21.4) 2228 (21.0) 2933 (27.7) 5250 (35.0) 3327 (22.1) 3068 (20.4) 3374 (22.5)
Spain 4440 (29.3) 3339 (22.0) 3277 (21.6) 4096 (27.0) 8500 (34.2) 5677 (22.8) 5244 (21.1) 5436 (21.9)
Italy 4129 (29.5) 3054 (21.8) 2984 (21.3) 3850 (27.5) 10 390 (34.1) 6426 (21.1) 6091 (20.0) 7590 (24.9)
France 20 508 (30.1) 15 379 (22.6) 14 764 (21.7) 17 398 (25.6)
Northern countries 31 420 (30.5) 22 109 (21.5) 21 277 (20.7) 28 029 (27.3) 66 243 (33.5) 44 357 (22.5) 40 739 (20.6) 46 112 (23.3)
United Kingdom 7632 (33.4) 4484 (19.6) 4306 (18.8) 6454 (28.2) 16 587 (31.5) 10 466 (19.9) 10 393 (19.7) 15 218 (28.9)
The Netherlands 2633 (26.9) 2348 (24.0) 2285 (23.3) 2518 (25.7) 8210 (30.9) 6288 (23.7) 5785 (21.8) 6246 (23.5)
Germany 5539 (26.7) 4993 (23.1) 4871 (22.6) 6181 (28.6) 7857 (28.1) 6520 (23.4) 6412 (23.0) 7126 (25.5)
Sweden 7935 (35.6) 5022 (22.5) 4507 (20.2) 6181 (28.6) 8230 (31.2) 6504 (24.7) 5942 (22.5) 5704 (21.6)
Denmark 7681 (29.2) 5262 (20.0) 5308 (20.2) 8032 (30.6) 9382 (32.6) 6017 (20.9) 5779 (20.1) 7558 (26.3)
Norway 15.977 (45.3) 8562 (24.3) 6428 (18.2) 4260 (12.1)
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study is that measurement of exposure and possible confounders
was carried out only once. Diet and lifestyle information was only
ascertained at enrolment measuring habits over the 12-months
period preceding the enrolment. It is possible that changes in diet
and possible confounders have occurred during the follow-up time
of this study (median time: 8.7 years).
Using the modified score (Trichopoulou et al, 2005) to
investigate the effect of Mediterranean diet on cancer risk
represents a compromise between the need to identify the
beneficial aspect of this dietary pattern and the need to assess it
in non-Mediterranean countries. Some important features of the
Mediterranean diet are not captured by the score, such as the use
of wine during meals as main source of alcohol and of olive oil as
main source of unsaturated fat. The extent to which these features
are important in mediating the effects of the Mediterranean diet on
health is not easily quantifiable. The HR estimates calculated in a
prospective study, however, would probably be biased towards the
null on account of misclassification in the scoring assessment. The
lack of a systematic difference in results between Mediterranean
and non-Mediterranean countries (Table 2) argues in favour of the
ability of the modified score (Trichopoulou et al, 2005) to
adequately characterise the biologically relevant features of the
Mediterranean diet. To construct the score, country-, and sex-
specific medians of considered food groups were calculated.
However, when using study-wide sex-specific medians, obtained
results were similar. A recent analysis of the Greek EPIC cohort has
identified moderate alcohol drinking, followed by low consump-
tion of meat, and high consumption of vegetables, fruits and nuts,
olive oil, and legumes as the most important components for the
effect of the Mediterranean diet on overall survival (Trichopoulou
et al, 2009). To evaluate whether the protective effect observed in
this analysis was predominantly because of a specific component
of the score, we performed sensitivity analyses eliminating one
component at a time from the score, as well as alcohol and an
another component at a time. These analyses did not suggest a
predominant effect of a specific component (results not shown)
and support the hypothesis that the beneficial effect is because of
the combined effect of a range of nutrient and non-nutrient
components, provided by a diet rich in antioxidants, fiber and
phytochemicals and with a favourable fatty acid profile.
Potential biological interactions among different nutrients
within the components of the Mediterranean diet score may be
Table 2 Hazard ratios for all cancers associated with a two-point increment of the Mediterranean diet score by EPIC participating countries
Men Women Both sexes
Cases HRa (95% CI) Cases HRb (95% CI) Cases HRa,b (95% CI)
Southern countries
Greece 402 0.85 (0.76–0.96) 400 0.86 (0.76–0.97) 802 0.86 (0.79–0.94)
Spain 938 0.94 (0.86–1.01) 999 1.05 (0.97–1.14) 1937 0.99 (0.94–1.05)
Italy 735 0.97 (0.89–1.06) 1676 0.96 (0.91–1.02) 2411 0.97 (0.92–1.02)
France 6514 0.98 (0.95–1.01) 6514 0.98 (0.95–1.01)
Overall 2075 0.93 (0.88–0.99) 9589 0.98 (0.95–1.00) 11 537 0.97 (0.95–0.99)
Northern countries
United Kingdom 1689 1.02 (0.97–1.08) 2907 0.96 (0.92–1.02) 4596 0.98 (0.95–1.02)
The Netherlands 311 0.93 (0.81–1.08) 1667 0.96 (0.90–1.02) 1978 0.96 (0.90–1.01)
Germany 1395 1.01 (0.94–1.08) 1299 0.94 (0.88–1.01) 2694 0.98 (0.93–1.02)
Sweden 2324 0.98 (0.93–1.04) 2286 0.96 (0.91–1.01) 4610 0.97 (0.93–1.01)
Denmark 1875 0.90 (0.86–0.95) 2161 0.93 (0.88–0.98) 4036 0.92 (0.89–0.95)
Norway 1153 0.98 (0.91–1.07) 1153 0.98 (0.91–1.07)
Overall 7594 0.97 (0.94–0.99) 11 473 0.95 (0.93–0.98) 19 067 0.96 (0.94–0.98)
P for heterogeneity between groups of countries 0.27 0.10 0.48
Overall 9669 0.97 (0.95–1.00) 21 062 0.96 (0.95–0.98) 30 731 0.96 (0.95–0.98)
Overall unadjustedc 9669 0.95 (0.92–0.97) 21 062 0.96 (0.95–0.98) 30 731 0.96 (0.94–0.97)
Overall without Greeced 9267 0.97 (0.95–1.00) 20 662 0.96 (0.95–0.98) 29 929 0.97 (0.95–0.98)
Abbreviations: CI¼ confidence interval; EPIC¼ European Prospective Investigation into Cancer and Nutrition; HR¼ hazard ratio. aStratified by centre and (for both sexes) sex,
and adjusted for smoking status, duration of smoking, education, height, body mass index, total energy intake, physical activity. bAdjusted for all the above variables, and age at
menarche, parity, menopausal status, oral contraceptive and hormone therapy use. cAnalyses were only stratified by centre and (for both sexes) sex. dResults for the Greek EPIC
cohort were published previously (Benetou et al, 2008) and were excluded to present new results separately.
Table 3 Hazard ratios for all cancers associated with categories of the
Mediterranean diet score
Score Cohort members Cases HRa (95% CI)
Both sexes
0–3 154 052 10 349 1.00
4 105 936 6849 0.96 (0.93–0.99)
5 99 672 6225 0.92 (0.89–0.95)
6–9 118 818 7308 0.93 (0.90–0.96)
P for trend¼ 0.00001
Men
0–3 43 161 3044 1.00
4 30 770 2121 0.99 (0.93–1.04)
5 29 766 2049 0.97 (0.92–1.03)
6–9 38 908 2455 0.93 (0.88–0.99)
P for trend¼ 0.02
Women
0–3 110 891 7305 1.00
4 75 166 4728 0.95 (0.91–0.98)
5 69 906 4176 0.90 (0.87–0.94)
6–9 79 910 4853 0.93 (0.89–0.96)
P for trend¼ 0.0001
Abbreviations: CI¼ confidence interval; HR¼ hazard ratio. aStratified by centre and
sex, and adjusted for smoking status, duration of smoking, education, height, body
mass index, total energy intake, physical activity and, for women, age at menarche,
parity, menopausal status, oral contraceptive and hormone therapy use.
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difficult to detect because of power limitations. The Mediterranean
diet scoring approach (Trichopoulou et al, 1995) accommodates
likely nutritional confounding, and captures possible effect
modification among foods (Jacques and Tucker, 2001). One
limitation of the score is that it gives equal weight to its
components and only considers whether consumption of each
component is above or below a certain threshold. The score was
also calculated taking into account the absolute consumption of
each component (see Appendix). The results of this method did
not provide additional insights. We therefore relied on the results
based on the standard scoring approach, which is simpler and
intuitively appealing.
The EPIC study offers a unique possibility to investigate the
relationship between adherence to Mediterranean dietary pattern
and overall cancer risk. This is the case not only because of its
large sample size, but also because information on diet and
potential confounding factors was gathered prospectively, and is
therefore unaffected by recall bias. Furthermore, one specific
advantage of this study is the inclusion of a geographically diverse
population including Mediterranean and non-Mediterranean
countries. The diet of the participants is, therefore, heterogeneous
and this study allows to investigate the association between
conformity to Mediterranean dietary pattern and overall cancer
risk both in Mediterranean and non-Mediterranean countries,
which, to our knowledge, has not been carried out before.
No difference in cancer risk associated with adherence to a
Mediterranean dietary pattern was found between Mediterranean
and non-Mediterranean countries, suggesting that the beneficial
effect of the Mediterranean dietary pattern on health is also
relevant to non-Mediterranean populations. It should be noted,
however, that these results do not exclude the possibility that other
diets, such as the traditional Dutch diet (Waijers et al, 2006), might
also potentially positively impact not only on total mortality but
also on cancer risk.
Our results indicate that higher adherence to a Mediterranean
dietary pattern is associated with a reduction in the risk of
cancer in Mediterranean and non-Mediterranean countries, with a
somewhat stronger protective effect among smokers and against
tobacco-related cancers. Promoting the Mediterranean diet might
therefore contribute to cancer prevention, in addition to
cardiovascular disease prevention (Fung et al, 2009). This also
applies to Mediterranean countries, in which diet is shifting away
from the traditional pattern and increasingly includes meat and
fat of animal origin (Trichopoulos and Lagiou, 2004; Balanza
et al, 2007).
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Table 4 Daily intake of foods groups considered in the Mediterranean
diet score and associated hazard ratios for overall cancer
Mean±s.d. Incrementa HRb (95% CI)
Overall score 4.4±1.7 2 0.96 (0.95–0.98)
Fruits and nuts (g per day) 247.3±197.2 200 0.98 (0.96–0.99)
Vegetables (g per day) 211.2±146.1 145 0.97 (0.95–0.98)
Legumes (g per day) 14.6±23.4 25 1.00 (0.99–1.02)
Cereals (g per day) 219.0±110.8 110 0.97 (0.95–0.98)
Dairy products (g per day) 326.7±235.2 235 1.01 (0.99–1.02)
Fish (g per day) 37.2±35.8 35 1.01 (0.99–1.02)
Meat (g per day) 98.7±6.3 60 1.02 (1.01–1.04)
Monounsaturated lipids (g per day) 30.9±13.8 15 1.01 (0.98–1.04)
Polyunsaturated lipids (g per day) 14.2±6.5 5 0.98 (0.97–1.00)
Saturated lipids (g per day) 31.5±13.0 15 1.01 (0.99–1.04)
Ratio of unsaturated to
saturated lipids (g per day)
1.5±0.5 0.5 0.98 (0.96–0.99)
Alcoholc
Light drinkers 1.9±2.2 1.03 (1.00–1.06)
Moderate drinkers 16.3±10.0 1.00
Heavy drinkers 51.8±25.4 1.12 (1.07–1.16)
Abbreviations: CI¼ confidence interval; HR¼ hazard ratio. aThe increment is
approximately equal to the standard deviation (except for the Mediterranean diet
score). bStratified by centre and sex, and adjusted for duration of smoking, smoking
status, education, height, body mass index, total energy intake, physical activity and,
for women, age at menarche, parity, menopausal status, oral contraceptive and
hormone therapy use. cLight drinkers: o10 g of ethanol per day for men and o5 g
per day for women; moderate drinkers: 10 too50 g per day for men and 5 too25 g
per day for women; heavy drinkers: X50 g per day for men and X25 g per day for
women. HRs of cancer risk for category of alcohol consumption were calculated
using moderate drinkers as the baseline category.
Table 5 HRs for all cancers associated with a two-point increment of the
Mediterranean diet score for each category of tobacco smoking status
Cases HRa (95% CI)
All cancers 30 731 0.96 (0.95–0.98)
Never smokers 13 787 0.98 (0.96–1.00)
Former smokers 8860 0.96 (0.93–0.98)
Current smokers 7439 0.94 (0.91–0.97)
P for heterogeneity¼ 0.07
Cancers known to be related
to smokingb,c
8000 0.92 (0.89–0.94)
Never smokers 2392 0.95 (0.90–0.99)
Former smokers 2490 0.93 (0.89–0.98)
Current smokers 3009 0.88 (0.84–0.92)
P for heterogeneity¼ 0.04
Cancers not known to be
associated with smokingc,d
11 218 0.98 (0.96–1.01)
Never smokers 5645 0.97 (0.94–1.01)
Former smokers 3205 0.99 (0.94–1.03)
Current smokers 2104 0.99 (0.94–1.04)
P for heterogeneity¼ 0.73
Abbreviations: CI¼ confidence interval; HR¼ hazard ratio. aStratified by centre and
sex, and adjusted for duration of smoking, smoking status, education, height, body
mass index, total energy intake, physical activity, age at menarche, parity, menopausal
status, oral contraceptive and hormone therapy use. bSmoking-associated cancers
include cancers of the lung, kidney, upper aero-digestive tract, stomach, pancreas,
bladder, liver and colorectal. cP for heterogeneity of smoking unrelated cancers vs
smoking related cancers¼ 0.0008 dSmoking-unrelated cancers include cancers of the
breast, prostate, and endometrium.
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APPENDIX
Additional analyses were performed using a more quantitative
Mediterranean diet score, based on the same nine dietary components:
intake of fruits and nuts, vegetables, legumes, cereals, lipids, fish, dairy
and meat products, and alcohol. The consumption of each component
was log-transformed, country- and sex-specific means were calculated
(means of log-transformed values approximate medians), and the
distance to the mean was estimated for each component. This value
was multiplied by 1 for components more consumed in Mediterranean
countries (vegetables, legumes, fruits and nuts, cereals, fish, unsatu-
rated-to-saturated lipid ratio), and 1 for those less consumed
components (meat and dairy products). For alcohol intake, the score
was calculated as Zm/s, where Z¼ 0 if the consumption Y falls in the
‘good’ interval (5 and o25 g per day for women, and 10 to o50 for
men), Z¼Ymin if Yomin, and Z¼maxY if Y4max; mZ¯, ssd
(z). These components were then summed up to obtain an overall
score. A high overall Mediterranean diet score shows a high adherence
to the Mediterranean dietary pattern and the opposite for a low score.
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